Inspection·February 27, 2026

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. Based on review of facility policy and clinical records and staff interviews it was determined that the facility failed to make certain controlled substances were accounted for accurately for nine of twelve residents (Resident R1, R2, R3, R4, R5, R6, R7, R8, and R9).Findings include: The facility policy Medication Administration - General Guidelines last reviewed 2/1/26, indicated The individual who administers the medication dose records the administration on the resident's MAR (medication administration record) directly after the medication is given. Review of Resident R1's MAR (medication administration record) for February 2026, revealed an order for oxycodone 5mg (a narcotic pain medication used to treat moderate to severe pain) to be given every six hours as needed for pain. Ten administrations were documented on the MAR from 2/5/26, through 2/27/26. Review of Resident R1's Controlled Substance Record indicated that 15 additional doses of oxycodone were signed out without corresponding documentation of administration to the resident on 2/6/26, 2/7/26, 2/12/26, 2/14/26, 2/15/26, 2/16/26 (x2), 2/17/26, 2/18/26, 2/20/26, 2/22/26, 2/24/26, 2/25/26, and 2/26/26. Review of Resident R2's MAR for February 2026, revealed an order for Endocet 5-325 (a oxycodone and acetaminophen) half-tablet to be given every six hours as needed for moderate pain, and one tablet to be given every six hours for severe pain. Nineteen administrations were documented from 2/7/26, through 2/26/26. Review of Resident R2's Controlled Substance Record indicated that six additional doses of Endocet were signed out without corresponding documentation of administration to the resident on 2/3/26, 2/15/26, 2/17/26 (x2), 2/20/26, and 2/24/26. Review of Resident R3's MAR for February 2026, revealed an order for Endocet 5-325 one tablet to be given every six hours for severe pain. Nineteen administrations were documented from 2/5/26, through 2/26/26. Review of Resident R3's Controlled Substance Record indicated that ten additional doses of Endocet were signed out without corresponding documentation of administration to the resident on 2/6/26, 2/10/26, 2/14/26, 2/16/26 , 2/17/26, 2/20/26, 2/23/26 (x2), 2/24/26, and 2/25/26. Review of Resident R4's MAR for February 2026, revealed an order for oxycodone 5mg to be given every four hours as needed for pain. Twelve administrations were documented on the MAR from 2/14/26, through 2/27/26. Review of Resident R4's Controlled Substance Record indicated that seven additional doses of oxycodone were signed out without corresponding documentation of administration to the resident on 2/14/26, 2/15/26, 2/16/26, 2/17/26, 2/23/26, 2/24/26, and 2/26/26. Review of Resident R5's MAR for February 2026, revealed an order for Endocet 5-325 (a oxycodone and acetaminophen) half-tablet to be given every six hours as needed for moderate pain, and one tablet to be given every six hours for severe pain. Four administrations were documented on the MAR from 2/17/26, through 2/27/26. Review of Resident R5's Controlled Substance Record indicated that six additional doses of Endocet were signed out without corresponding documentation of administration to the resident on 2/17/26, 2/20/26, 2/23/26, 2/24/26, 2/25/26, and 2/26/26. Review of Resident R6's MAR for February 2026, revealed an order for oxycodone 5mg to be given every four hours as needed for pain. Three administrations were documented on the MAR from 2/25/26, (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 395903 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 395903 B. Wing A. Building (X3) DATE SURVEY COMPLETED 02/27/2026 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Harmony Hills Healthcare and Rehabilitation Center 194 Swinderman Road Wexford, PA 15090 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)